Literature DB >> 21898385

Morbidity and mortality in gynecological cancers among first- and second-generation immigrants in Sweden.

Seyed Mohsen Mousavi1, Kristina Sundquist, Kari Hemminki.   

Abstract

We studied the effect of new environment on the risk in and mortality of gynecological cancers in first- and second-generation immigrants in Sweden. We used the nationwide Swedish Family-Cancer Database to calculate standardized incidence/mortality ratios (SIRs/SMRs) of cervical, endometrial and ovarian cancers among immigrants in comparison to the native Swedes. Risk of cervical cancer increased among first-generation immigrants with Danish (SIR = 1.64), Norwegian (1.33), former Yugoslavian (1.21) and East European (1.35) origins, whereas this risk decreased among Finns (0.88) and Asians (SIRs varies from 0.11 in Iranians to 0.54 in East Asians). Risk of endometrial (SIRs varies from 0.28 in Africans to 0.86 in Finns) and ovarian (SIRs varies from 0.23 in Chileans to 0.82 in Finns) cancers decreased in first-generation immigrants. The overall gynecological cancer risk for the second-generation immigrants, independent of the birth region, was almost similar to that obtained for the first generations. The birth region-specific SMRs of gynecological cancers in first- and second-generation immigrants co-varied with the SIRs. Risk of gynecological cancers among the first-generation immigrants is similar to that in their original countries, except for cervical cancer among Africans and endometrial cancer among North Americans and East Europeans. Our findings show that risk and mortality of gynecological cancers observed in the first-generation immigrants remain in the second generation. We conclude that the risk and protective factors of gynecological cancers are preserved upon immigration and through generations, suggesting a role for behavioral factors or familial aggregation in the etiology of these diseases.
Copyright © 2011 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 21898385     DOI: 10.1002/ijc.26395

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Evaluation of prevalent and incident ovarian cancer co-morbidity.

Authors:  K Stålberg; T Svensson; F Granath; H Kieler; B Tholander; S Lönn
Journal:  Br J Cancer       Date:  2012-05-01       Impact factor: 7.640

Review 2.  Hispano-Americans in Europe: what do we know about their health status and determinants? A scoping review.

Authors:  Maria Roura; Andreu Domingo; Juan M Leyva-Moral; Robert Pool
Journal:  BMC Public Health       Date:  2015-05-07       Impact factor: 3.295

3.  HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs.

Authors:  Cinzia Campari; Chiara Fedato; Alessio Petrelli; Manuel Zorzi; Carla Cogo; Adele Caprioglio; Federica Gallo; Livia Giordano; Serena Domenighini; Luigi Pasquale; Sonia Prandi; Marco Zappa; Paolo Giorgi Rossi
Journal:  Infect Agent Cancer       Date:  2015-05-07       Impact factor: 2.965

4.  Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy.

Authors:  Maria Lina Tornesello; Paolo Giorgi Rossi; Luigi Buonaguro; Franco Maria Buonaguro
Journal:  Front Oncol       Date:  2014-02-20       Impact factor: 6.244

5.  Causes of death among undocumented migrants in Sweden, 1997-2010.

Authors:  Anna Wahlberg; Carina Källestål; AnnaCarin Lundgren; Birgitta Essén
Journal:  Glob Health Action       Date:  2014-06-03       Impact factor: 2.640

6.  Perceived cervical cancer risk among women treated for high-grade cervical intraepithelial neoplasia: The importance of specific knowledge.

Authors:  Sonia Andersson; Karen Belkić; Selin Safer Demirbüker; Miriam Mints; Ellinor Östensson
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

Review 7.  Mortality by country of birth in the Nordic countries - a systematic review of the literature.

Authors:  Helena Honkaniemi; Jennie Bacchus-Hertzman; Johan Fritzell; Mikael Rostila
Journal:  BMC Public Health       Date:  2017-05-25       Impact factor: 3.295

8.  Is self-sampling to test for high-risk papillomavirus an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia?

Authors:  Sonia Andersson; Karen Belkić; Miriam Mints; Ellinor Östensson
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.